Modification of a model of non-alcoholic fat liver disease in rats with a сombination of a hypercaloric diet and hypodynamia

Author:

Bunjat A. V.1ORCID,Spasenkova O. M.2ORCID,Karev V. E.3ORCID,Karavaeva A. V.2ORCID,Ivkin D. Ju.2ORCID,Kulikov A. N.1ORCID,Okovityi S. V.2ORCID,Kirillova N. V.2ORCID

Affiliation:

1. V. A. Almazov NMRC

2. Saint-Petersburg State Chemical-Pharmaceutical University

3. Federal Medical and Biological Agency Federal State Institution Scientific and Research Institute of Children’s Infections

Abstract

Introduction. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world, and non-alcoholic steatohepatitis is the second most common cause of liver transplantation in the adult population. An urgent task is to find and develop an optimal model of NAFLD in laboratory animals, which would reproduce all the features of this disease in the clinic.Aim. Modification of the NAFLD model in laboratory animals (rats), which allows the obtained data to be transmitted to humans as fully as possible.Materials and methods. The study was conducted on 52 outbred white male rats of the same age. As the basis of the model, a hypercaloric high-fat diet was used with the addition of food appeal enhancers (sodium glutamate and liquid shrimp extract) and for the first-time conditions of hypodynamia were used – restriction of the motor activity of animals using specially designed cells, in which an individual 11 × 18 cm cell was allocated for each individual. The duration of the study was 12 months. In the course of the experiment, body weight, physical performance, biochemical parameters of blood serum and urine in dynamics were assessed, and lethality was recorded. After the end of the study, the mass of internal organs, visceral and epididymal fat was analyzed, and a histological examination of the liver was performed.Results and discussion. In the course of the experimental study, the development of NAFLD in rats of the control group of animals was histologically confirmed. A high mortality rate was revealed in the group of animals with pathology. Compared with animals of the intact group, a statistically significant increase in their body weight, liver weight, visceral and epididymal fat, a decrease in physical performance, disturbances in lipid, carbohydrate and protein metabolism were revealed, as well as signs of deterioration of the protein synthesis and excretory functions of the liver.Conclusion. A number of advantages of the NAFLD model with a combination of a hypercaloric diet and hypodynamic conditions were revealed, including the similarity of the conditions for the formation and pathogenesis of the disease in experimental animals and humans, which ensures the adequacy of data translation from preclinical practice to clinical practice.

Publisher

Center of Pharmaceutical Analytics Ltd

Subject

Drug Discovery,Pharmaceutical Science

Reference33 articles.

1. European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL–EASD–EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology. 2016;64(6):1388–1402. DOI: 10.1016/j.jhep.2015.11.004.

2. Lazebnik L. B., Golovanova E. V., Turkina S. V., Raikhelson K. L., Okovityy S. V., Drapkina O. M., Maev I. V., Martynov A. I., Roitberg G. E., Khlynova O. V., Abdulganieva D. I., Alekseenko S. A., Ardatskaya M. D., Bakulin I. G., Bakulina N. V., Bueverov A. O., Vinitskaya E. V., Volynets G. V., Eremina E. Yu., Grinevich V. B., Dolgushina A. I., Kazyulin A. N., Kashkina E. I., Kozlova I. V., Konev Yu. V., Korochanskaya N. V., Kravchuk Yu. A., Li E. D., Loranskaya I. D., Makhov V. M., Mekhtiev S. N., Novikova V. P., Ostroumova O. D., Pavlov Ch. S., Radchenko V. G., Samsonov A. A., Sarsenbaeva A. S., Sayfutdinov R. G., Seliverstov P. V., Sitkin S. I., Stefanyuk O. V., Tarasova L. V., Tkachenko E. I., Uspensky Yu. P., Fominykh Yu. A., Khavkin A. I., Tsyganova Yu. V., Sharhun O. O. Non-alcoholic fatty liver disease in adults: clinical picture, diagnosis, treatment. Guidelines for therapists, third version. Jeksperimental’naja i Klinicheskaja Gastrojenterologija = Experimental and Clinical Gastroenterology. 2021;1(1):4–52. (In Russ.) DOI: 10.31146/1682-8658-ecg-185-1-4-52.

3. Cariou B., Byrne C. D., Loomba R., Sanyal A. J. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes, Obesity and Metabolism. 2021;23(5):1069–1083. DOI: 10.1111/dom.14322.

4. Drapkina O. M., Ivashkin V. T. Epidemiological features of non-alcoholic fatty liver disease in Russia (results of an open multicenter prospective observation study DIREGL 01903). Rossijskij Zhurnal Gastrojenterologii, Gepatologii, Koloproktologii = Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2014;24(4):32–38. (In Russ.)

5. Cotter T. G., Charlton M. Nonalcoholic steatohepatitis after liver transplantation. Liver Transplantation. 2020;26(1):141–159. DOI: 10.1002/lt.25657.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3